Weekly Market Pulse
August payrolls came in at 162,000, more than five times the average monthly gain of the prior twelve months, and the unemployment rate held at 4.1%. The index tape barely moved on the week, but underneath it energy and semiconductors led while application software had its worst five sessions of the quarter.
A strong jobs number, a flat index and a very wide spread underneath it
The S&P 500 closed the week at 7,718.60, 0.09% above the previous Friday. That number hides the real story. Over the same five sessions the oil tracker gained 9.45%, semiconductors gained 2.56% and the application-software tracker lost 4.50%. When the index is flat and the spread between the best and the worst tracked sleeve is close to fourteen points, the tape is telling you where money is moving, not whether it is leaving.
The payroll trend was revised upward twice
Nonfarm payrolls rose 162,000 in August against an average monthly gain of 31,000 over the prior twelve months. June was revised from +20,000 to +31,000 and July from −23,000 to +21,000, adding 55,000 jobs to the two previous months. Unemployment stayed at 4.1%.
Crude repriced on shipping, not on demand
The oil tracker gained 9.45% on the week, with 5.46% of it on Tuesday alone, and the energy sector added 2.20%. The July FOMC statement had already named the conflict in the Middle East and energy supply shocks as sources of price pressure, which puts this move inside the policy debate rather than beside it.
Software and semiconductors moved in opposite directions
Semiconductors gained 2.56% and application software lost 4.50% in the same five sessions. Inside software the single-name spread was wider still: Snowflake rose 16.6% on Thursday after raising its full-year outlook, while Guidewire lost 19.9% on Friday and MongoDB lost 13.5% on Wednesday.
Bull case to confirm
- The labour data holds its improved trend without forcing the front end of the curve materially higher into the September FOMC.
- The August CPI and PPI prints on 10 and 11 September keep energy out of the core measures.
- Semiconductor leadership broadens into the rest of technology instead of offsetting software weakness one week at a time.
Bear case to disprove
- A firm labour market plus a crude shock hardens the case for a rate increase rather than a hold on 16 September.
- Software de-rating continues to spread from single names to the sector, as it did on Friday when the tracker lost 2.23%.
- Aerospace and defence, industrials and consumer discretionary all fell on the week; a fourth week of the same pattern would make it a rotation, not noise.
Telix Pharmaceuticals has a Prescription Drug User Fee Act target action date of 11 September 2026 for Pixclara (floretyrosine F 18), a PET imaging agent for glioma, used to distinguish recurrence and progression from post-treatment change. The date is stated in the company’s own filing. It is the first confirmed regulatory decision date since 28 August. Merlintrader keeps the running file on the company in the Telix Stock Hub.
Friday
Market map: energy and chips up, software and defence down
Four of the eleven sector trackers finished the week higher and the largest single move in the map was energy. The three weakest sleeves were consumer discretionary, real estate and materials, and outside the sector map aerospace and defence lost more than three per cent. That is a market rewarding real assets and cash flows priced off commodities, not one rewarding duration.
| Ticker | Instrument / sector | Week | 28 Aug close | Friday |
|---|---|---|---|---|
| $SMH | Semiconductors | +2.56% | $552.84 | +2.59% |
| $XLE | Energy | +2.20% | $62.68 | −0.87% |
| $XLK | Technology | +0.86% | $185.69 | +0.70% |
| $XLU | Utilities | +0.82% | $42.73 | +0.12% |
| $QQQ | Nasdaq-100 tracker | +0.37% | $716.31 | +0.20% |
| $XLV | Health Care | +0.17% | $171.16 | −1.04% |
| $MDY | Mid caps | +0.14% | $690.55 | +0.13% |
| $SPY | S&P 500 tracker | +0.11% | $769.35 | −0.39% |
| $IWM | Small caps | +0.09% | $295.75 | +0.28% |
| $XLF | Financials | 0.00% | $58.10 | −0.79% |
| $DIA | Dow tracker | −0.18% | $535.06 | −0.53% |
| $XLC | Communication Services | −0.85% | $112.99 | −1.19% |
| $XLP | Consumer Staples | −1.02% | $85.45 | −0.80% |
| $XLI | Industrials | −1.06% | $177.14 | +0.41% |
| $XLRE | Real Estate | −1.24% | $44.48 | −0.72% |
| $XLB | Materials | −1.39% | $53.18 | −0.34% |
| $XLY | Consumer Discretionary | −1.96% | $117.21 | −1.33% |
| $ITA | Aerospace and defence | −3.10% | $232.82 | −0.16% |
| $IGV | Application software | −4.50% | $109.50 | −2.23% |
Weekly change is computed close to close between 28 August and 4 September 2026 from the Marketstack end-of-day series, which is the paid market-data source used across Merlintrader. The Friday column is shown separately so a single session is never mistaken for the week.
Cross-asset map: the oil move had no equivalent anywhere else
The cross-asset picture is unusually one-sided. Crude and the oil equity complex rose, everything with duration fell slightly, and gold and silver both lost ground in a week with a shipping crisis in the Gulf. Precious metals falling while crude rises nine per cent argues that the market read the week as a supply event with rate consequences, not as a generic flight to safety.
| Ticker | Instrument | Week | 28 Aug close | Friday |
|---|---|---|---|---|
| $USO | Crude oil tracker | +9.45% | $129.70 | −0.09% |
| $XOP | Oil and gas exploration | +2.57% | $185.94 | −0.84% |
| $EWJ | Japan equities | +2.51% | $95.87 | +0.39% |
| $EEM | Emerging markets | +2.32% | $67.14 | +1.82% |
| $UNG | Natural gas tracker | +2.23% | $10.33 | +0.67% |
| $KRE | Regional banks | +1.31% | $74.30 | +0.53% |
| $URA | Uranium | +1.08% | $45.57 | +0.79% |
| $XBI | Equal-weight biotech | +0.88% | $162.38 | −0.35% |
| $SLV | Silver | −0.33% | $60.02 | −1.21% |
| $UUP | U.S. dollar tracker | −0.35% | $28.18 | +0.25% |
| $GLD | Gold | −0.52% | $408.89 | −0.84% |
| $TLT | Long Treasuries | −0.73% | $82.81 | +0.22% |
| $HYG | High-yield credit | −0.73% | $79.74 | −0.06% |
| $LQD | Investment-grade credit | −0.82% | $106.35 | −0.02% |
| $JETS | Airlines | −1.30% | $29.18 | +1.34% |
| $REMX | Rare earths and strategic metals | −2.27% | $77.42 | −0.49% |
| $LIT | Lithium and battery | −2.48% | $76.07 | −0.38% |
| $XAR | Aerospace and defence, equal weight | −3.39% | $261.79 | −0.40% |
| $COPX | Copper miners | −3.98% | $94.42 | −0.65% |
One line deserves to be read on its own. Aerospace and defence lost three per cent in a week in which a shipping lane carrying a fifth of the world’s seaborne crude was disrupted. Whatever the market was pricing in that sleeve, it was not a straightforward conflict premium, and any reading that assumes otherwise is contradicted by the tape.
Sessions in review: 31 August – 4 September
The week was a round trip with a very uneven interior. Monday and Tuesday took the indexes down about one per cent, Wednesday and Thursday took it all back, and Friday gave part of it away after the payroll release. Application software fell in four of the five sessions.
| Session | S&P 500 | Nasdaq-100 | Small caps | Semis | Software | Read-through |
|---|---|---|---|---|---|---|
| Mon 31 | −0.33% | +0.08% | −0.62% | +0.74% | +0.44% | Quiet start, crude already up 3.08%. |
| Tue 1 | −0.71% | −1.29% | −1.14% | −2.11% | −3.46% | The week’s risk-off session: crude +5.46%, gold −2.86%, VIX up to 16.34. |
| Wed 2 | +0.46% | +0.23% | +1.18% | +0.98% | −2.60% | Index recovery with software still falling; Dell gained 15.8%. |
| Thu 3 | +1.06% | +1.16% | +0.40% | +0.39% | +3.41% | Strongest session of the week; Snowflake +16.6%. |
| Fri 4 | −0.38% | +0.21% | +0.28% | +2.59% | −2.23% | Payroll day: chips up, software and consumer down. |
Index changes are computed on the S&P 500 and Nasdaq-100 index levels; small caps, semiconductors and software use the IWM, SMH and IGV closes. All values recomputed close to close from the Marketstack end-of-day series.
Macro: a firmer labour market, expanding surveys and a curve that moved a little higher
The August Employment Situation
Nonfarm payroll employment rose 162,000 in August against an average monthly gain of 31,000 over the prior twelve months, and the unemployment rate was unchanged at 4.1%, with 7.0 million people unemployed. The composition matters as much as the total. Food services and drinking places added 59,000 jobs and local government education added 42,000, largely offsetting a decline in the prior month. Manufacturing continued its upward trend at +16,000 and is up 58,000 since a recent low in December 2025. Information employment fell 23,000, with losses in computing infrastructure providers, data processing and web hosting (−8,000), publishing (−7,000) and broadcasting and content providers (−5,000).
Average hourly earnings rose 10 cents, or 0.3%, to $37.75, and are up 3.1% over the year. The labour force participation rate edged up to 61.6% but is down half a point since January. June was revised up 11,000 to +31,000 and July up 44,000 to +21,000, so the two prior months together are 55,000 higher than previously reported. The number of people employed part time for economic reasons fell 414,000 to 4.4 million.
The two ISM surveys
Manufacturing expanded for an eighth consecutive month, with the PMI at 54.6% in August against 55.6% in July. New orders fell 3.0 points to 53.7 and backlogs fell 3.2 points to 51.8, both still in expansion; production was almost unchanged at 58.3 and employment cooled 1.6 points to 51.2. The services survey went the other way: the Services PMI rose 1.3 points to 55.4%, its 26th month of expansion, with business activity at 61.7 and new orders at 60.9, while the employment index contracted for a second consecutive month at 47.8.
The two employment sub-indexes point in opposite directions and neither of them is the payroll survey. Reading them together, the August picture is one of firm activity with hiring that is no longer broad-based, which is exactly the combination that keeps a policy debate open rather than closing it.
The Treasury curve
Yields drifted higher across the curve. The two-year moved from 4.34% on 28 August to 4.37% on 4 September, the ten-year from 4.73% to 4.78% and the thirty-year from 5.22% to 5.24%. The gap between the two-year and the ten-year widened from 39 to 41 basis points. These are small weekly moves; the larger repricing happened earlier, with the two-year up from 3.38% at the end of February.
What the Federal Reserve has already said
The Committee left the target range for the federal funds rate at 3.50% to 3.75% on 29 July 2026, by a nine to three vote. Beth M. Hammack, Neel Kashkari and Lorie K. Logan voted against, preferring to raise the target range by a quarter point at that meeting. The statement described economic activity as expanding at a solid pace despite elevated uncertainty that owes, in part, to the conflict in the Middle East, said inflation remains elevated relative to the 2% goal in part reflecting supply shocks that have driven price increases in certain sectors including energy, and closed with the sentence “The Committee will deliver price stability.” The next decision is on 16 September.
Earnings: the widest single-name dispersion of the quarter
Nine companies of size reported between Monday and Thursday and the share reactions ranged from plus fifteen per cent to minus twenty-one per cent on the week. The operating figures below come from each company’s own release or its Form 8-K exhibit. The weekly share move is a separate market observation, computed close to close, and is not presented as a single-cause explanation of the result.
| Company | Reported | Official operating signal | Weekly share move |
|---|---|---|---|
| $DELL | 1 Sep, after the close | Q2 FY2027 revenue $46.971 billion, +58%; non-GAAP diluted EPS $7.04. FY2027 revenue outlook raised to $192.0 billion from $167.0 billion, with AI-optimised server revenue guided to $74.0 billion from $60.0 billion. Record orders of $60.9 billion and backlog of $95 billion cited by management. | +14.88% |
| $SNOW | 2 Sep, after the close | Q2 FY2027 revenue $1.547 billion, +35%; product revenue $1.492 billion, +37%; net revenue retention 126%. FY2027 product revenue guidance raised to $6,070 million, +36%, from $5,840 million, and non-GAAP operating margin to 14.5% from 13.5%. | +2.80% |
| $DOCU | 3 Sep, after the close | Second-quarter results above the company’s own prior guidance, with the fiscal 2027 outlook raised. | +6.89% |
| $CRM | Reported the prior week | No new release in this window; shown for context on the software complex. | +1.26% |
| $CRWD | Reported the prior week | No new release in this window; shown for context on the security complex. | −2.43% |
| $AVGO | 2 Sep, after the close | Q3 FY2026 revenue $29.591 billion, +86%; non-GAAP diluted EPS $3.32, +96%. AI semiconductor revenue $16.7 billion, +221% year on year and +54% sequentially, with $21.7 billion expected in Q4. Q4 revenue guided to approximately $34.8 billion, +93%. | −2.95% |
| $ZS | 3 Sep, after the close | Q4 FY2026 revenue $898.2 million, +25%; ARR $3,771 million, +25%. First FY2027 guidance: revenue $3.908–3.938 billion, growth of 16.6% to 17.5%. A separate Form 8-K discloses a plan committed to on 1 September to reduce worldwide headcount by approximately 3%, with charges of $30.0 to $33.0 million. | −7.83% |
| $LULU | 3 Sep, after the close | Q2 net revenue $2.416 billion, −4%; comparable sales −9%. GAAP diluted EPS $2.92, of which $0.86 came from IEEPA tariff refunds. Full-year revenue outlook now $10.350–10.500 billion against $11.000–11.150 billion previously, and EPS $9.48–9.73 against $10.95–11.15. | −16.72% |
| $MDB | 1 Sep, after the close | Q2 FY2027 revenue $771.8 million, +30%; non-GAAP EPS $1.90. Full-year FY2027 guidance raised to $2.99–3.03 billion from $2.92–2.96 billion, with the company attributing the second-half increase mainly to Atlas. | −17.44% |
| $PATH | 3 Sep, after the close | Q2 FY2027 revenue $410.3 million, +13%; ARR $1.938 billion, +12%; dollar-based net retention 109%. FY2027 revenue, ARR and non-GAAP operating income guidance all above the May figures. Hitesh Ramani promoted to Chief Financial Officer. | −16.31% |
| $GWRE | 3 Sep, after the close | Q4 revenue $411.1 million, +15%; FY2026 revenue $1,475.4 million, +23%. ARR $1,242 million at 31 July 2025 exchange rates, +19% in constant currency. FY2027 guidance: ending ARR $1,450–1,460 million, total revenue $1,707–1,727 million. | −21.10% |
Three of these companies raised full-year guidance and still fell. MongoDB raised its fiscal 2027 revenue outlook by seventy million dollars and lost 17.44% on the week; UiPath raised revenue, ARR and operating income and lost 16.31%; Zscaler beat every line of its own May guidance and lost 7.83% after issuing a first fiscal 2027 outlook implying growth of roughly seventeen per cent against twenty-five per cent delivered. Whatever is being repriced in enterprise software this year is not the current quarter.
A note on one figure that is often quoted and is not disclosed. MongoDB publishes only the growth rate of Atlas revenue, approximately 29% year on year, and its share of total revenue, 73% in the quarter from the Form 10-Q. The company does not publish an Atlas revenue figure in dollars, so any absolute number in circulation is a third-party calculation and not a company disclosure.
Biotech: no confirmed regulatory decision date fell in this week
Between 28 August and 11 September there is no Prescription Drug User Fee Act target date, advisory committee meeting or other confirmed regulatory decision date in the Merlintrader register of catalysts verified on primary sources. The eight approvals of the second half of August — Ultragenyx, Regeneron, Jazz and Zymeworks, Revolution Medicines, Gilead, Roivant and Protagonist — had all been decided before this window opened. The sector traded accordingly and without a company-specific driver: equal-weight biotech gained 0.88% and large-cap biotech 1.40%, both roughly in line with the index.
The next four confirmed dates
- 11 September — $TLX, Pixclara (floretyrosine F 18), PET imaging in glioma. PDUFA target date.
- 19 September — $RARE, UX111 (rebisufligene etisparvovec) gene therapy in Sanfilippo syndrome type A. PDUFA target date.
- 21 September — $MRK, Winrevair (sotatercept-csrk), label update in pulmonary arterial hypertension. PDUFA target date on the supplemental application.
- 22 September — $IONS, zilganersen, an antisense oligonucleotide for Alexander disease. PDUFA target date.
How this list is built
Only dates confirmed on a primary source enter it: a company filing with the Securities and Exchange Commission, an investor relations release, or an FDA page. Windows such as “third quarter” or “second half” are not converted into a day, and estimated completion dates taken from clinical trial registries are kept separate. The full running list, with the source next to each date, is in the Free Biotech Catalyst Calendar.
A target action date is a deadline for the agency to act, not a forecast of the outcome and not a schedule the agency is bound to meet. Extensions happen, and when they do they are recorded on the same page.
One advisory committee follows immediately after: the FDA has scheduled a meeting on 23 September to discuss the GRAIL Galleri multi-cancer early detection test. Advisory committee recommendations are not binding on the agency.
Verified calendar: 7 – 11 September
United States markets are closed on Monday 7 September for Labor Day. All times are U.S. Eastern Time and come from the issuing agency’s own release schedule or the company’s own announcement. Schedules can change, and the linked primary source remains controlling.
| Date | Verified event | Why it matters |
|---|---|---|
| Mon 7 Sep | Labor Day. U.S. equity markets closed; no BLS release scheduled. | Four trading sessions in the week, with the two inflation prints stacked at the end. |
| Tue 8 Sep | Oracle fiscal first-quarter results. No BLS release scheduled. | The first large read on enterprise and cloud demand after a week in which raised guidance did not protect software shares. |
| Wed 9 Sep | Employer Costs for Employee Compensation, June 2026, 10:00 a.m. Results from AeroVironment, Chewy, Academy Sports and Outdoors, Signet Jewelers, American Eagle Outfitters, SailPoint, Core & Main and The Cooper Companies. | The densest small and mid cap earnings day of the week, across defence, consumer and software. |
| Thu 10 Sep | Producer Price Index, August 2026, 8:30 a.m. Results from Adobe, RH, Macy’s, Descartes Systems, Uranium Royalty and Tsakos Energy Navigation. | The first of the two August inflation readings, five sessions before the FOMC decision. |
| Fri 11 Sep | Consumer Price Index, August 2026, 8:30 a.m., and Real Earnings, 8:30 a.m. Kroger results. PDUFA target date for Telix’s Pixclara. | The single highest-impact scheduled release of the week, in a month in which energy prices moved sharply. |
What would improve the setup
- August CPI and PPI absorb the crude move without lifting the core measures, leaving the September decision genuinely open.
- Semiconductor strength persists and begins to pull the wider technology complex with it rather than offsetting software week by week.
- Consumer names reporting on Wednesday and Thursday show that the Lululemon guidance cut was company-specific rather than a category signal.
What would worsen it
- A hot CPI on Friday combines with the strong payroll number and pushes the front end of the curve up into the 16 September decision.
- Application software extends a fourth consecutive week of underperformance, turning a de-rating into a sector trend.
- Further disruption to shipping in the Gulf keeps crude rising, which would move from a sector rotation to an input-cost problem for industrials and consumer names.
Verification sources and methodology
Prices, index levels and every percentage change in this edition are computed close to close from the Marketstack end-of-day series, the paid market-data source used across Merlintrader, on 4 September 2026. Treasury yields come from the Department of the Treasury daily yield curve. Every operating figure comes from the company’s own release or its Form 8-K exhibit on the Securities and Exchange Commission site. Macro figures come from the issuing agency.
- BLS, The Employment Situation, August 2026
- BLS, release schedule for September 2026
- U.S. Treasury, daily yield curve rates
- Federal Reserve, FOMC statement of 29 July 2026
- ISM Manufacturing PMI, August 2026
- ISM Services PMI, August 2026
- Broadcom Q3 FY2026, Form 8-K exhibit
- Dell Technologies Q2 FY2027, Form 8-K exhibit
- Snowflake Q2 FY2027, Form 8-K exhibit
- Guidewire Q4 and FY2026 results
- Lululemon Q2 2026, Form 8-K exhibit
- Zscaler Q4 and FY2026, Form 8-K exhibit
- Zscaler Form 8-K, Item 2.05 restructuring
- MongoDB Q2 FY2027, Form 8-K exhibit
- UiPath Q2 FY2027, Form 8-K exhibit
- Telix filing with the Pixclara target action date
Transparency boundary
No sell-side consensus, price target or probability of approval is used anywhere in this edition. No regulatory date is retained unless it appears on a primary source. Where a company does not disclose a figure, the absence is stated rather than filled with a third-party estimate. Market interpretation is kept separate from confirmed facts, and every interpretive paragraph is written as such.
Get the next Weekly Pulse in real time
Join the Merlintrader Telegram channel for market recaps, biotech catalyst updates and Stock Hub refreshes as they go live.
Join @merlintraderpub_com on TelegramFree Biotech Catalyst Calendar
Track upcoming PDUFA dates, FDA advisory committees, clinical readouts and regulatory decisions in one place.
Open the Biotech Catalyst Calendar


